Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (861-870 of 1,115) with videos related to

Pageof 112
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2016
At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia CellsUri Rozovski, David M Harris, Ping Li, et al.
Leukemia|December 22, 2019
The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironmentEkaterina Kim, Elisa Ten Hacken, Mariela Sivina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignanciesJ Kurtzberg, T J Ernst, M J Keating, et al.
British Journal of Haematology|November 10, 2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)Gheath Alatrash, Maher Albitar, Susan O'Brien, et al.
Atherosclerosis|January 3, 2015
Subclinical atherosclerosis and increased risk of hearing impairmentMary E Fischer, Carla R Schubert, David M Nondahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patientsApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.
Blood|August 7, 2007
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3George F Widhopf, Craig J Goldberg, Traci L Toy, et al.
American Journal of Clinical Pathology|April 17, 2009
Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genesC Cameron Yin, Katherine I-Chun Lin, Rhett P Ketterling, et al.
Leukemia|October 22, 2020
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemiaMariela Sivina, Lianchun Xiao, Ekaterina Kim, et al.
British Journal of Cancer|February 18, 2011
Infrared spectroscopy with multivariate analysis to interrogate endometrial tissue: a novel and objective diagnostic approachS E Taylor, K T Cheung, I I Patel, et al.
Pageof 112

Showing results (861-870 of 1,115) with videos related to

Sort By:
Pageof 112
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2016
At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia CellsUri Rozovski, David M Harris, Ping Li, et al.
Leukemia|December 22, 2019
The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironmentEkaterina Kim, Elisa Ten Hacken, Mariela Sivina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignanciesJ Kurtzberg, T J Ernst, M J Keating, et al.
British Journal of Haematology|November 10, 2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)Gheath Alatrash, Maher Albitar, Susan O'Brien, et al.
Atherosclerosis|January 3, 2015
Subclinical atherosclerosis and increased risk of hearing impairmentMary E Fischer, Carla R Schubert, David M Nondahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patientsApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.
Blood|August 7, 2007
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3George F Widhopf, Craig J Goldberg, Traci L Toy, et al.
American Journal of Clinical Pathology|April 17, 2009
Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genesC Cameron Yin, Katherine I-Chun Lin, Rhett P Ketterling, et al.
Leukemia|October 22, 2020
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemiaMariela Sivina, Lianchun Xiao, Ekaterina Kim, et al.
British Journal of Cancer|February 18, 2011
Infrared spectroscopy with multivariate analysis to interrogate endometrial tissue: a novel and objective diagnostic approachS E Taylor, K T Cheung, I I Patel, et al.
Pageof 112